Global Drug Eluting Balloons (DEB) Supply, Demand and Key Producers, 2026-2032
Description
The global Drug Eluting Balloons (DEB) market size is expected to reach $ 1974 million by 2032, rising at a market growth of 12.8% CAGR during the forecast period (2026-2032).
A drug-eluting balloon is a non-stent technology in which the effective homogenous delivery of anti-proliferative drugs is processed by the vessel wall through an inflated balloon. This is done to restore luminal vascularity in order to treat atherosclerosis, in-stent restenosis and reduce the risk of late thrombosis without implanting a permanent foreign object. The balloon technology relies on the concept of targeted drug delivery, which helps in the rapid healing of the vessel wall and prevents the proliferation of smooth muscle cells. Drug eluting balloon is a semi-compliant angioplasty balloon, coated with anti-proliferative medicine. The medicine is ejected to the vessel walls during the inflation of the balloon. The balloons are inflated through application of nominal pressure.
The Drug Eluting Balloons (DEB) market is being driven by the increasing global prevalence of cardiovascular diseases, particularly peripheral artery disease (PAD) and coronary artery disease (CAD). DEBs offer an effective alternative to traditional stents by delivering antiproliferative drugs directly to the vessel wall without leaving a permanent implant, reducing restenosis rates and improving long-term outcomes. Growing patient preference for minimally invasive procedures and shorter recovery times is also contributing to the adoption of DEBs. Furthermore, advancements in drug delivery technologies and increased clinical evidence supporting DEB efficacy are encouraging broader usage, especially among high-risk patients.
Despite their benefits, the DEB market faces several challenges. One key issue is the lack of uniform clinical guidelines and inconsistent results from clinical trials, which may hinder physician confidence and limit widespread adoption. Additionally, the high cost of DEBs compared to conventional balloons or bare-metal stents can be a barrier, particularly in emerging economies with limited healthcare budgets. Regulatory complexities and lengthy approval processes also pose significant hurdles for manufacturers. Furthermore, reimbursement policies vary across regions, creating market access disparities and limiting patient availability to these advanced therapies.
The DEB market is witnessing key trends such as the development of next-generation balloons with enhanced drug coatings and more efficient drug release profiles. There is growing interest in DEBs for treating new indications beyond peripheral and coronary artery disease, such as in-stent restenosis, small vessel disease, and arteriovenous fistula stenosis. Integration of imaging technologies, like intravascular ultrasound (IVUS) and optical coherence tomography (OCT), is also improving procedural outcomes. Additionally, strategic collaborations between medtech companies and research institutions are accelerating innovation, while increasing focus on personalized medicine is expected to drive customized DEB solutions in the near future.
Global Drug Eluting Balloons（DEB） key players include B. Braun, Medtronic, Boston Scientific, BD, Yinyi, etc. Global top 5 manufacturers hold a share over 84%. Europe is the largest market, with a share about 42%, followed by North America, and Asia-Pacific, both have a share about 52 percent.
This report studies the global Drug Eluting Balloons (DEB) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Drug Eluting Balloons (DEB) and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Drug Eluting Balloons (DEB) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Drug Eluting Balloons (DEB) total production and demand, 2021-2032, (K Units)
Global Drug Eluting Balloons (DEB) total production value, 2021-2032, (USD Million)
Global Drug Eluting Balloons (DEB) production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Drug Eluting Balloons (DEB) consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Drug Eluting Balloons (DEB) domestic production, consumption, key domestic manufacturers and share
Global Drug Eluting Balloons (DEB) production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Drug Eluting Balloons (DEB) production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Drug Eluting Balloons (DEB) production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Drug Eluting Balloons (DEB) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include B. Braun, Medtronic, Boston Scientific, BD, Yinyi, Philips, Eurocor, Aachen Resonance, Biotronic, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Drug Eluting Balloons (DEB) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Drug Eluting Balloons (DEB) Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Drug Eluting Balloons (DEB) Market, Segmentation by Type:
Peripheral DEBs
Coronary DEBs
Global Drug Eluting Balloons (DEB) Market, Segmentation by Application:
Catheterization Laboratory
Hospital
Others
Companies Profiled:
B. Braun
Medtronic
Boston Scientific
BD
Yinyi
Philips
Eurocor
Aachen Resonance
Biotronic
Key Questions Answered:
1. How big is the global Drug Eluting Balloons (DEB) market?
2. What is the demand of the global Drug Eluting Balloons (DEB) market?
3. What is the year over year growth of the global Drug Eluting Balloons (DEB) market?
4. What is the production and production value of the global Drug Eluting Balloons (DEB) market?
5. Who are the key producers in the global Drug Eluting Balloons (DEB) market?
6. What are the growth factors driving the market demand?
A drug-eluting balloon is a non-stent technology in which the effective homogenous delivery of anti-proliferative drugs is processed by the vessel wall through an inflated balloon. This is done to restore luminal vascularity in order to treat atherosclerosis, in-stent restenosis and reduce the risk of late thrombosis without implanting a permanent foreign object. The balloon technology relies on the concept of targeted drug delivery, which helps in the rapid healing of the vessel wall and prevents the proliferation of smooth muscle cells. Drug eluting balloon is a semi-compliant angioplasty balloon, coated with anti-proliferative medicine. The medicine is ejected to the vessel walls during the inflation of the balloon. The balloons are inflated through application of nominal pressure.
The Drug Eluting Balloons (DEB) market is being driven by the increasing global prevalence of cardiovascular diseases, particularly peripheral artery disease (PAD) and coronary artery disease (CAD). DEBs offer an effective alternative to traditional stents by delivering antiproliferative drugs directly to the vessel wall without leaving a permanent implant, reducing restenosis rates and improving long-term outcomes. Growing patient preference for minimally invasive procedures and shorter recovery times is also contributing to the adoption of DEBs. Furthermore, advancements in drug delivery technologies and increased clinical evidence supporting DEB efficacy are encouraging broader usage, especially among high-risk patients.
Despite their benefits, the DEB market faces several challenges. One key issue is the lack of uniform clinical guidelines and inconsistent results from clinical trials, which may hinder physician confidence and limit widespread adoption. Additionally, the high cost of DEBs compared to conventional balloons or bare-metal stents can be a barrier, particularly in emerging economies with limited healthcare budgets. Regulatory complexities and lengthy approval processes also pose significant hurdles for manufacturers. Furthermore, reimbursement policies vary across regions, creating market access disparities and limiting patient availability to these advanced therapies.
The DEB market is witnessing key trends such as the development of next-generation balloons with enhanced drug coatings and more efficient drug release profiles. There is growing interest in DEBs for treating new indications beyond peripheral and coronary artery disease, such as in-stent restenosis, small vessel disease, and arteriovenous fistula stenosis. Integration of imaging technologies, like intravascular ultrasound (IVUS) and optical coherence tomography (OCT), is also improving procedural outcomes. Additionally, strategic collaborations between medtech companies and research institutions are accelerating innovation, while increasing focus on personalized medicine is expected to drive customized DEB solutions in the near future.
Global Drug Eluting Balloons（DEB） key players include B. Braun, Medtronic, Boston Scientific, BD, Yinyi, etc. Global top 5 manufacturers hold a share over 84%. Europe is the largest market, with a share about 42%, followed by North America, and Asia-Pacific, both have a share about 52 percent.
This report studies the global Drug Eluting Balloons (DEB) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Drug Eluting Balloons (DEB) and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Drug Eluting Balloons (DEB) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Drug Eluting Balloons (DEB) total production and demand, 2021-2032, (K Units)
Global Drug Eluting Balloons (DEB) total production value, 2021-2032, (USD Million)
Global Drug Eluting Balloons (DEB) production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Drug Eluting Balloons (DEB) consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Drug Eluting Balloons (DEB) domestic production, consumption, key domestic manufacturers and share
Global Drug Eluting Balloons (DEB) production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Drug Eluting Balloons (DEB) production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Drug Eluting Balloons (DEB) production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Drug Eluting Balloons (DEB) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include B. Braun, Medtronic, Boston Scientific, BD, Yinyi, Philips, Eurocor, Aachen Resonance, Biotronic, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Drug Eluting Balloons (DEB) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Drug Eluting Balloons (DEB) Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Drug Eluting Balloons (DEB) Market, Segmentation by Type:
Peripheral DEBs
Coronary DEBs
Global Drug Eluting Balloons (DEB) Market, Segmentation by Application:
Catheterization Laboratory
Hospital
Others
Companies Profiled:
B. Braun
Medtronic
Boston Scientific
BD
Yinyi
Philips
Eurocor
Aachen Resonance
Biotronic
Key Questions Answered:
1. How big is the global Drug Eluting Balloons (DEB) market?
2. What is the demand of the global Drug Eluting Balloons (DEB) market?
3. What is the year over year growth of the global Drug Eluting Balloons (DEB) market?
4. What is the production and production value of the global Drug Eluting Balloons (DEB) market?
5. Who are the key producers in the global Drug Eluting Balloons (DEB) market?
6. What are the growth factors driving the market demand?
Table of Contents
110 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World Manufacturers Competitive Analysis
- 4 United States VS China VS Rest of the World
- 5 Market Analysis by Type
- 6 Market Analysis by Application
- 7 Company Profiles
- 8 Industry Chain Analysis
- 9 Research Findings and Conclusion
- 10 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
